Ledger.Open graph →
SEC Form D · filed June 7, 2011

Pathway Therapeutics, Inc

Offering
$9.7M
Sold
$7.5M
Exemption
—
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (7)

Julie Cherrington · San Francisco, CAExec · DirectorJoshua Funder · Melbourne, Channel IslandsDirectorRyan D. Cahill · Evanston, ILExec · DirectorWill Charles · Auckland, Q2DirectorJoshua Funder · Stamford, CTDirectorMark Harvey · Brisbane, Channel IslandsDirectorHillary Lewis · Mt. Eden, Auckland, Q2Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗